Predictmedix AI Inc. (F:3QP0) — Market Cap & Net Worth
Market Cap & Net Worth: Predictmedix AI Inc. (3QP0)
Predictmedix AI Inc. (F:3QP0) has a market capitalization of $3.14 Million (€2.69 Million) as of April 21, 2026. Listed on the F stock exchange, this Germany-based company holds position #33051 globally and #4729 in its home market, demonstrating a -10.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predictmedix AI Inc.'s stock price €0.01 by its total outstanding shares 206787542 (206.79 Million).
Predictmedix AI Inc. Market Cap History: 2026 to 2026
Predictmedix AI Inc.'s market capitalization history from 2026 to 2026. Data shows growth from $3.14 Million to $3.14 Million (0.00% CAGR).
Predictmedix AI Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predictmedix AI Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 3QP0 by Market Capitalization
Companies near Predictmedix AI Inc. in the global market cap rankings as of April 21, 2026.
Key companies related to Predictmedix AI Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $168.34 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #148 globally with a market cap of $131.38 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #185 globally with a market cap of $110.50 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #224 globally with a market cap of $95.25 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $168.34 Billion | $96.81 |
| #148 | Stryker Corporation | NYSE:SYK | $131.38 Billion | $343.32 |
| #185 | Medtronic PLC | NYSE:MDT | $110.50 Billion | $86.19 |
| #224 | Boston Scientific Corp | NYSE:BSX | $95.25 Billion | $64.23 |
Predictmedix AI Inc. Historical Marketcap From 2026 to 2026
Between 2026 and today, Predictmedix AI Inc.'s market cap moved from $3.14 Million to $ 3.14 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.14 Million | -- |
End of Day Market Cap According to Different Sources
On Apr 20th, 2026 the market cap of Predictmedix AI Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.14 Million USD |
| MoneyControl | $3.14 Million USD |
| MarketWatch | $3.14 Million USD |
| marketcap.company | $3.14 Million USD |
| Reuters | $3.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Predictmedix AI Inc.
Predictmedix AI Inc. develops artificial intelligence powered technologies for general workplace health and safety, and health care industry. It operates in two segments, Workplace Health and Safety, and Healthcare. The company offers infectious disease symptom screening solutions to identify persons who test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID… Read more